To know the impact of COVID-19 On Vocal Biomarkers Market Size, Share & Trends Analysis Report By Type (Frequency, Amplitude, Error Rate, Voice Rise/fall time, Phonation Time, Voice Tremor, Pitch, Others), By End-users (Hospitals and Clinics, Academic and Research, Others) Based on Region, And Segment Forecasts, 2022 - 2028 Market
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027
Global Vocal Biomarkers Market is valued at USD 1658.4 Million in 2020 and is expected to reach USD 4658.8 Million by 2027 with a CAGR of 15.9% over the forecast period.
Global Vocal Biomarkers Market: Global Size, Trends, Competitive, Historical & Forecast Analysis to 2021-2027, Increasing demand of vocal biomarkers with the increasing prevalence of Parkinson’s disease & other diseases, growing applications of vocal biomarkers in healthcare and security purposes, and rising research & developments in this field are some of the major factors anticipated to drive the growth of Global Vocal Biomarkers Market.
Scope of Global Vocal Biomarkers Market:
Vocal-biomarkers is a technique that allows machines to understand human emotions by examining, recording, and detecting raw voice intonations as people speak. Biomarkers within the voice of an individual are linked to disorders like depression, arteria coronaria disease, and anxiety. By decoding the human vocal intonations into their underlying emotions in real-time, this technology enables the applications and solutions, voice-powered devices to interact at the emotional level, even as humans do. Psychiatrists and clinical psychologists are using vocal patterns of subjects/patients for decades to research their personality traits and help gain in medical and clinical investigations.
Sound vibrations are used as biomarkers within the diagnosis of varied psychological state disorders like anxiety and depression. It measures the features of speech but doesn't require the contents of the speech, therefore protecting privacy. They are ready to detect some diseases before a mean check-up process, and an earlier diagnosis could essentially be the difference between life and death in reference to certain illnesses. Vocal biomarkers, with advancement in technology, could soon be employed by psychologists or psychiatrists to instantly diagnose PTSD, postpartum depression in new mothers, certain cancers, heart conditions, and even dementia, Parkinson’s disease.
The COVID-19 pandemic has shown a positive impact on the global vocal biomarkers market. As the mental health of people was lowered due to lockdown, people are at home so the stress of stopped business and people lost their jobs during pandemics their fore financial problems led to increased depression, symptoms of anxiety or depression and people suffered from an anxiety disorder. The use of verbal biomarkers helped in the treatment of psychological disorders. Also, a number of studies are examining the potential to use vocal biomarkers for voice analysis to support the identification of Covid-19 and as an aid to the monitoring of respiratory symptoms of Covid-19. A number of companies are focusing on developing new vocal biomarkers for screening users' Covid 19 and pulmonary hypertension (PH) and on monitoring patients with chronic diseases such as congestive heart failure (CHF)and chronic obstructive pulmonary disease (COPD). Thus verbal biomarkers market growth is positive during pandemics.
Global Vocal Biomarkers Market Segmentation:
The global vocal biomarkers market is segmented on the basis of type, end-users, and region & country level. On the basis of type, the market is segmented into frequency, amplitude, error rate, voice rise/fall time, phonation time, voice tremor, pitch, and others. On the basis of end-users, the market is segmented into hospitals and clinics, academics, research, and others.
By Type: -
- Error Rate
- Voice Rise/fall time
- Phonation Time
- Voice Tremor
By End-users: -
- Hospitals and Clinics
- Academic and Research
The regions covered in the global vocal biomarkers market report are North America, Europe, Asia-Pacific, Latin America, and the Rest of the World. On the basis of country level, the market of global vocal biomarkers market is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
Vocal Biomarker Companies
Some of the key players of the global vocal biomarkers market are
- Boston Technology Corporation
- Microtest Health
- Sonde Health
- IBM Corporation
- Audio Profiling
- Cogito Corporation
News: Sonde Health Launched Vocal Biomarker Technology to Monitor Mental Health and Well-Being.
On October 5th, 2021; Sonde Mental Fitness is a voice-enabled mental health detection and monitoring technology unveiled by Sonde Health. For evaluating mental well-being it uses a brief voice sample and it is available as an application programming interface (API) for wellness service providers, health systems, and employers. This Sonde Mental Fitness is an easy and affordable way for individuals for engaging with & better understand their mental well-being. Also, it can serve as a much-needed early warning system for depression and other mental health conditions. This Sonde Mental Fitness also utilizes biomarkers to measure key indicators of health which is the same as a physical fitness tracker. It is powered by audio signal processing technology and its machine learning models are trained on more than one million voice samples from all over the world and have been optimized for voices across dialects, cultures, and languages.
Increasing Demand of Vocal Biomarkers due to Rising Prevalence of Parkinson’s disease and Other Diseases, Growing Applications Vocal Biomarkers in Healthcare & Other Fields is Driving the Market Growth
One of the major factors driving the growth of the global vocal biomarkers market is the increasing demand of vocal biomarkers due to the rising prevalence of Parkinson’s disease and other diseases. Parkinson's disease (PD) is another most normal degenerative neurological problem after Alzheimer's disease. For instance; according to Parkinson’s Foundation nearly one million people in the U.S. are living with Parkinson's disease (PD) and this is expected to rise to 1.2 million by 2030. Thus, due the prevalence of these diseases, there is increasing demand for vocal biomarkers as human voice biomarkers offer understanding about neurological disorders, like Parkinson’s disease (PD), due to their underlying cognitive and neuromuscular function. In, the decrease in motor control in voice biomarkers is the symbol of the disease, and voice can be used as a means to detect and diagnose Parkinson’s disease.
Also, the growing popularity of the development in technology and the occurrence of audio collecting devices in daily lives, also consistent models that can translate the audio information into a diagnostic tool for healthcare professionals would potentially give diagnoses that are cheaper and more correct. In addition to that, the vocal biomarkers have shown application in remote health monitoring of the heart-patient with the testing voice of the patient with coronary artery disease and recognizing depression &stress. Moreover, vocal biomarkers also find applications in the detection of lies. Thus, vocal biomarkers are utilized by defense association security agencies while investing a criminal. Vocal biomarkers account for 38% of the analysis of lie detection tests stated officials with international safety agencies which is propelling the demand for vocal biomarkers over the forecast period.
However, significant errors in the vocal features and inaccuracies of boundaries of words may hamper the growth of the global vocal biomarkers market. In spite of that, research is being done to discover disease biomarkers in the diagnosis of Parkinson's disease, traumatic brain damage, cognitive impairment, and respiratory diseases offer various opportunities in the global vocal biomarkers market.
North America is Expected to Dominate the Global Vocal Biomarkers Market
North America is expected to dominate the global vocal biomarkers market due to increasing mental health disorders, the presence of key players, facilities, and technological advancements in this region. For example; according to the Alzheimer’s Association; in 2017, about 5.5 million people in the U.S suffered from Alzheimer's and dementia, which demands rapid research on biomarkers for early detection of Alzheimer's Disease. In addition to that, medical reimbursement policies and increasing healthcare expenditure in the region contribute to the growth of the market. Also, 39% of the increase in the death rate is due to neurological disorders according to the U.S. National Library of Medicine. Thus, Vocal biomarkers are in high demand as neurological disorders were the leading cause of DALYs (Disability Adjusted Life Years) and the second leading cause of death.
Also, Europe is the second-largest region in the global vocal biomarkers market due to increasing awareness and growing healthcare expenditure in this region. In Europe, there is growing awareness regarding diseases can affect organs such as the heart, lungs, brain, muscles, or vocal folds, which can then alter an individual’s voice. People in the European region are aware of voice analysis by using artificial intelligence for diagnosis, risk prediction, and remote monitoring of various clinical outcomes and symptoms and the various applications of voice for health-related purposes. Therefore, voice analysis using artificial intelligence like voice biomarkers has opened new opportunities for the healthcare sector in Europe. Thus, many companies are focusing on launching new voice analysis technological products. For, example; Sonde Health launched a replacement version of its vocal biomarker technology which aims to diagnose diseases from a person’s voice patterns that it says can be wont to monitor psychological state and wellbeing. It is boosting the growth of the vocal biomarkers in the European region.
On Special Requirement vocal biomarkers market Report is also available for below Regions and Country:
- Rest of Europe
- South Korea
- Rest Of APAC
- Rest of South America
Middle East and Africa
- Saudi Arabia
- South Africa
- Rest Of MEA
Key Benefits of Global Vocal Biomarker Market:
- Global Vocal Biomarker Market report covers in-depth historical and forecast analysis.
- Global Vocal Biomarkers Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Vocal biomarker companies, Market Opportunities, Competitive Analysis, Regional and Country Level.
- Global Vocal Biomarker Market report helps to identify opportunities in the marketplace.
- Global Vocal Biomarker Market report covers extensive analysis of emerging trends and competitive landscape.
Frequently Asked Questions (FAQ) :
Interested in this report?
Vocal Biomarkers Market Size, Industry Share, Trends, And Forecast By 2027